Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Weis (Jena, Germany), H. Kirsten (Leipzig, Germany), E. Grunow (Jena, Germany), P. Ahnert (Leipzig, Germany), G. Nouailles (Berlin, Germany), M. Kiehntopf (Jena, Germany), P. Creutz (Berlin, Germany), M. Löffler (Leipzig, Germany), N. Suttorp (Berlin, Germany), M. Witzenrath (Berlin, Germany), M. Bauer (Jena, Germany), M. Scholz (Leipzig, Germany). Data from the PROGRESS study - blood gene expression patterns predict severe outcome of community aqcuired pneumonia. 2029

Member's Comments

No comment yet.

Related content which might interest you: IL1RA polymorphism and levels associated with adverse outcome in severe community acquired pneumonia in children: A hospital-based study in India. Source: International Congress 2017 – Paediatric respiratory infections and immunity Year: 2017 An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Lung attacks in the ED: measurements to predict outcome. The AWARD study. Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Performance indicators to evaluate the management of patients with ventilator-associated pneumonia: results from the IMPACT-HAP study group Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Viral and M. pneumoniae community acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study Source: ERJ Open Res, 5 (1) 00014-2019; 10.1183/23120541.00014-2019 Year: 2019 Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged >=75 yrs Source: Eur Respir J 2001; 17: 200-205 Year: 2001 A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 Detailed analysis of health status of Q fever patients one year after the first Dutch outbreak: A case control study Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010